# Puma Biotechnology, Inc.: Form 8-K, filed Jun 13, 2025

- Company: [Puma Biotechnology, Inc.](/companies/pbyi.md) (CIK 1401667)
- Form: 8-K
- Filed: 2025-06-13
- Accepted by EDGAR: Jun 13, 2025, 16:07 ET
- Period: 2025-06-11
- Accession: 0001437749-25-020321
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401667/000143774925020321/pbyi20250612_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401667/000143774925020321/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401667/000143774925020321/pbyi20250612_8k.htm

Filed Jun 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-020321. Last ingested by Listed: Nov 15, 2026, 02:27 ET. No prices; not investment advice.
